Skip to main content
Erschienen in: International Urology and Nephrology 1/2024

18.05.2023 | Nephrology - Original Paper

Combinative predictive effect of left ventricular mass index, ratio of HDL and CRP for progression of chronic kidney disease in non-dialysis patient

verfasst von: Leile Tang, Shaomin Li, Xinghua Guo, Jiahui Lai, Peijia Liu, Jia Fang, Xun Liu

Erschienen in: International Urology and Nephrology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This current study scrutinized the association among left ventricular mass index (LVMI), ratio of high-density lipoprotein (HDL) and C-reactive protein (CRP), and renal function. Furthermore, we examined the predictive effects of left ventricular mass index and HDL/CRP on progression of non-dialysis chronic kidney disease.

Methods

We enrolled adult patients with chronic kidney disease (CKD) who were not receiving dialysis and obtained follow-up data on them. We extracted and compared data between different groups. To investigate the relationship between left ventricular mass index (LVMI), high-density lipoprotein (HDL)/C-reactive protein (CRP) levels, and CKD, we employed linear regression analysis, Kaplan–Meier analysis, and Cox proportional hazards regression analysis.

Results

Our study enrolled a total of 2351 patients. Compared with those in the non-progression group, subjects in the CKD progression group had lower ln(HDL/CRP) levels (− 1.56 ± 1.78 vs. − 1.14 ± 1.77, P < 0.001) but higher left ventricular mass index (LVMI) values (115.45 ± 29.8 vs. 102.8 ± 26.31 g/m2, P < 0.001). Moreover, after adjusting for demographic factors, ln(HDL/CRP) was found to be positively associated with estimated glomerular filtration rate (eGFR) (B = 1.18, P < 0.001), while LVMI was negatively associated with eGFR (B = − 0.15, P < 0.001). In the end, we found that both LVH (HR = 1.53, 95% CI 1.15 to 2.05, P = 0.004) and lower ln(HDL/CRP) (HR = 1.46, 95% CI 1.08 to 1.96, P = 0.013) independently predicted CKD progression. Notably, the combined predictive power of these variables was stronger than either variable alone (HR = 1.98, 95% CI 1.5 to 2.62, P < 0.001).

Conclusion

Our study findings indicate that in pre-dialysis patients, both HDL/CRP and LVMI are associated with basic renal function and are independently correlated with CKD progression. These variables may serve as predictors for CKD progression, and their combined predictive power is stronger than that of either variable alone.
Literatur
1.
Zurück zum Zitat Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822PubMedCrossRef Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822PubMedCrossRef
2.
Zurück zum Zitat Yeh HC, Lo YC, Ting IW, Chu PL, Chang SN, Chiang HY, Kuo CC (2020) 24-hour serum creatinine variation associates with short- and long-term all-cause mortality: a real-world insight into early detection of acute kidney injury. Sci Rep 10:6552PubMedPubMedCentralCrossRef Yeh HC, Lo YC, Ting IW, Chu PL, Chang SN, Chiang HY, Kuo CC (2020) 24-hour serum creatinine variation associates with short- and long-term all-cause mortality: a real-world insight into early detection of acute kidney injury. Sci Rep 10:6552PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Guo XS, Chen SQ, Duan CY, Li HL, Bei WJ, Liu Y, Tan N, Chen PY, Chen JY (2017) Association of post-procedural early (within 24h) increases in serum creatinine with all-cause mortality after coronary angiography. Clin Chim Acta 474:96–101PubMedCrossRef Guo XS, Chen SQ, Duan CY, Li HL, Bei WJ, Liu Y, Tan N, Chen PY, Chen JY (2017) Association of post-procedural early (within 24h) increases in serum creatinine with all-cause mortality after coronary angiography. Clin Chim Acta 474:96–101PubMedCrossRef
4.
Zurück zum Zitat Losito A, Nunzi E, Pittavini L, Zampi I, Zampi E (2018) Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine. J Nephrol 31:71–77PubMedCrossRef Losito A, Nunzi E, Pittavini L, Zampi I, Zampi E (2018) Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine. J Nephrol 31:71–77PubMedCrossRef
5.
Zurück zum Zitat Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D (2003) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63:654–661PubMedCrossRef Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D (2003) C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63:654–661PubMedCrossRef
6.
Zurück zum Zitat Chen S, Liu H, Liu X, Li Y, Li M, Liang Y, Shao X, Holthofer H, Zou H (2013) Central obesity C-reactive protein and chronic kidney disease: a community-based cross-sectional study in southern China. Kidney Blood Press Res 37:392–401PubMedCrossRef Chen S, Liu H, Liu X, Li Y, Li M, Liang Y, Shao X, Holthofer H, Zou H (2013) Central obesity C-reactive protein and chronic kidney disease: a community-based cross-sectional study in southern China. Kidney Blood Press Res 37:392–401PubMedCrossRef
7.
Zurück zum Zitat Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM (2007) Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 49:304–310PubMedCrossRef Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM (2007) Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension 49:304–310PubMedCrossRef
8.
Zurück zum Zitat Savoia C, Schiffrin EL (2006) Inflammation in hypertension. Curr Opin Nephrol Hypertens 15:152–158PubMed Savoia C, Schiffrin EL (2006) Inflammation in hypertension. Curr Opin Nephrol Hypertens 15:152–158PubMed
9.
Zurück zum Zitat Boos CJ, Lip GY (2006) Is hypertension an inflammatory process? Curr Pharm Des 12:1623–1635PubMedCrossRef Boos CJ, Lip GY (2006) Is hypertension an inflammatory process? Curr Pharm Des 12:1623–1635PubMedCrossRef
10.
Zurück zum Zitat Di Napoli M, Papa F (2006) Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens 8:187–194CrossRef Di Napoli M, Papa F (2006) Systemic inflammation, blood pressure, and stroke outcome. J Clin Hypertens 8:187–194CrossRef
11.
12.
13.
Zurück zum Zitat Ganjali S, Gotto AJ, Ruscica M, Atkin SL, Butler AE, Banach M, Sahebkar A (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233:9237–9246PubMedCrossRef Ganjali S, Gotto AJ, Ruscica M, Atkin SL, Butler AE, Banach M, Sahebkar A (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233:9237–9246PubMedCrossRef
14.
Zurück zum Zitat Usta A, Avci E, Bulbul CB, Kadi H, Adali E (2018) The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol 16:34PubMedPubMedCentralCrossRef Usta A, Avci E, Bulbul CB, Kadi H, Adali E (2018) The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome. Reprod Biol Endocrinol 16:34PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Zhan X, Pan D, Wei X, Wen D, Yan C, Xiao J (2020) Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis 30:1130–1136PubMedCrossRef Zhan X, Pan D, Wei X, Wen D, Yan C, Xiao J (2020) Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis 30:1130–1136PubMedCrossRef
16.
Zurück zum Zitat Gembillo G, Siligato R, Cernaro V, Satta E, Conti G, Salvo A, Romeo A, Calabrese V, Sposito G, Ferlazzo G, Santoro D (2022) Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients. Int Urol Nephrol 54:395–403PubMedCrossRef Gembillo G, Siligato R, Cernaro V, Satta E, Conti G, Salvo A, Romeo A, Calabrese V, Sposito G, Ferlazzo G, Santoro D (2022) Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients. Int Urol Nephrol 54:395–403PubMedCrossRef
17.
Zurück zum Zitat Nam KH, Chang TI, Joo YS, Kim J, Lee S, Lee C, Yun HR, Park JT, Yoo TH, Sung SA, Lee KB, Oh KH, Kim SW, Lee J, Kang SW, Choi KH, Ahn C, Han SH (2019) Association between serum high-density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW-CKD. J Am Heart Assoc 8:e11162CrossRef Nam KH, Chang TI, Joo YS, Kim J, Lee S, Lee C, Yun HR, Park JT, Yoo TH, Sung SA, Lee KB, Oh KH, Kim SW, Lee J, Kang SW, Choi KH, Ahn C, Han SH (2019) Association between serum high-density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW-CKD. J Am Heart Assoc 8:e11162CrossRef
18.
Zurück zum Zitat Kanda E, Ai M, Okazaki M, Yoshida M, Maeda Y (2016) Association of high-density lipoprotein subclasses with chronic kidney disease progression atherosclerosis, and klotho. PLoS ONE 11:e166459CrossRef Kanda E, Ai M, Okazaki M, Yoshida M, Maeda Y (2016) Association of high-density lipoprotein subclasses with chronic kidney disease progression atherosclerosis, and klotho. PLoS ONE 11:e166459CrossRef
19.
Zurück zum Zitat Li B, Liu HY, Guo SH, Sun P, Gong FM, Jia BQ (2015) Impact of early enteral and parenteral nutrition on prealbumin and high-sensitivity C-reactive protein after gastric surgery. Genetics Mol Res 14:7130–7135CrossRef Li B, Liu HY, Guo SH, Sun P, Gong FM, Jia BQ (2015) Impact of early enteral and parenteral nutrition on prealbumin and high-sensitivity C-reactive protein after gastric surgery. Genetics Mol Res 14:7130–7135CrossRef
20.
Zurück zum Zitat Freitas CO, Gomes-Filho IS, Naves RC, Nogueira FGR, Cruz SS, Santos CA, Dunningham L, Miranda LF, Barbosa MD (2012) Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci 20:1–8PubMedPubMedCentralCrossRef Freitas CO, Gomes-Filho IS, Naves RC, Nogueira FGR, Cruz SS, Santos CA, Dunningham L, Miranda LF, Barbosa MD (2012) Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci 20:1–8PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Block G, Jensen C, Dietrich M, Norkus EP, Hudes M, Packer L (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 23:141–147PubMedCrossRef Block G, Jensen C, Dietrich M, Norkus EP, Hudes M, Packer L (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 23:141–147PubMedCrossRef
22.
Zurück zum Zitat Demmer RT, Trinquart L, Zuk A, Fu BC, Blomkvist J, Michalowicz BS, Ravaud P, Desvarieux M (2013) The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 8:e77441PubMedPubMedCentralCrossRef Demmer RT, Trinquart L, Zuk A, Fu BC, Blomkvist J, Michalowicz BS, Ravaud P, Desvarieux M (2013) The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE 8:e77441PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Mitrovic V, Klein HH, Krekel N, Kreuzer J, Fichtlscherer S, Schirmer A, Paar WD, Hamm CW (2005) Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis. Z Kardiol 94:336–342PubMedCrossRef Mitrovic V, Klein HH, Krekel N, Kreuzer J, Fichtlscherer S, Schirmer A, Paar WD, Hamm CW (2005) Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis. Z Kardiol 94:336–342PubMedCrossRef
24.
Zurück zum Zitat Zheng X, Zeng N, Wang A, Zhu Z, Zhong C, Xu T, Xu T, Peng Y, Peng H, Li Q, Ju Z, Geng D, Zhang Y, He J (2018) Elevated C-reactive protein and depressed high-density lipoprotein cholesterol are associated with poor function outcome after ischemic stroke. Curr Neurovasc Res 15:226–233PubMedCrossRef Zheng X, Zeng N, Wang A, Zhu Z, Zhong C, Xu T, Xu T, Peng Y, Peng H, Li Q, Ju Z, Geng D, Zhang Y, He J (2018) Elevated C-reactive protein and depressed high-density lipoprotein cholesterol are associated with poor function outcome after ischemic stroke. Curr Neurovasc Res 15:226–233PubMedCrossRef
25.
Zurück zum Zitat Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Tanaka A, Matsunaga-Lee Y, Egami Y, Shutta R, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Suna S, Nakatani D, Hikoso S, Sakata Y (2021) High density lipoprotein cholesterol/C reactive protein ratio in heart failure with preserved ejection fraction. ESC Heart Failure 8:2791–2801PubMedPubMedCentralCrossRef Yano M, Nishino M, Ukita K, Kawamura A, Nakamura H, Matsuhiro Y, Yasumoto K, Tsuda M, Okamoto N, Tanaka A, Matsunaga-Lee Y, Egami Y, Shutta R, Tanouchi J, Yamada T, Yasumura Y, Tamaki S, Hayashi T, Nakagawa A, Nakagawa Y, Suna S, Nakatani D, Hikoso S, Sakata Y (2021) High density lipoprotein cholesterol/C reactive protein ratio in heart failure with preserved ejection fraction. ESC Heart Failure 8:2791–2801PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Agarwal R, Song RJ, Vasan RS, Xanthakis V (2020) Left ventricular mass and incident chronic kidney disease. Hypertension 75:702–706PubMedCrossRef Agarwal R, Song RJ, Vasan RS, Xanthakis V (2020) Left ventricular mass and incident chronic kidney disease. Hypertension 75:702–706PubMedCrossRef
27.
Zurück zum Zitat Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086–1119PubMed Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086–1119PubMed
28.
Zurück zum Zitat Drawz PE, Beddhu S, Bignall ON, Cohen JB, Flynn JT, Ku E, Rahman M, Thomas G, Weir MR, Whelton PK (2022) KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of blood pressure in CKD. Am J Kidney Dis 79:311–327PubMedCrossRef Drawz PE, Beddhu S, Bignall ON, Cohen JB, Flynn JT, Ku E, Rahman M, Thomas G, Weir MR, Whelton PK (2022) KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of blood pressure in CKD. Am J Kidney Dis 79:311–327PubMedCrossRef
29.
Zurück zum Zitat KDIGO (2020) Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 98(2020):S1–S115 KDIGO (2020) Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 98(2020):S1–S115
30.
Zurück zum Zitat Levin A, Agarwal R, Herrington WG, Heerspink HL, Mann J, Shahinfar S, Tuttle KR, Donner JA, Jha V, Nangaku M, de Zeeuw D, Jardine MJ, Mahaffey KW, Thompson AM, Beaucage M, Chong K, Roberts GV, Sunwold D, Vorster H, Warren M, Damster S, Malik C, Perkovic V (2020) International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int 98:849–859PubMedCrossRef Levin A, Agarwal R, Herrington WG, Heerspink HL, Mann J, Shahinfar S, Tuttle KR, Donner JA, Jha V, Nangaku M, de Zeeuw D, Jardine MJ, Mahaffey KW, Thompson AM, Beaucage M, Chong K, Roberts GV, Sunwold D, Vorster H, Warren M, Damster S, Malik C, Perkovic V (2020) International consensus definitions of clinical trial outcomes for kidney failure: 2020. Kidney Int 98:849–859PubMedCrossRef
31.
Zurück zum Zitat Harkness A, Ring L, Augustine DX, Oxborough D, Robinson S, Sharma V (2020) Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British society of echocardiography. Echo Res Practice 7:G1–G18CrossRef Harkness A, Ring L, Augustine DX, Oxborough D, Robinson S, Sharma V (2020) Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British society of echocardiography. Echo Res Practice 7:G1–G18CrossRef
32.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA-J Am Med Assoc 291:844–850CrossRef Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA-J Am Med Assoc 291:844–850CrossRef
33.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC (1999) The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22:743–751PubMedCrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC (1999) The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22:743–751PubMedCrossRef
34.
Zurück zum Zitat Kontush A (2014) HDL-mediated mechanisms of protection in cardiovascular disease. Cardiovasc Res 103:341–349PubMedCrossRef Kontush A (2014) HDL-mediated mechanisms of protection in cardiovascular disease. Cardiovasc Res 103:341–349PubMedCrossRef
35.
Zurück zum Zitat Cernaro V, Calabrese V, Loddo S, Corsaro R, Macaione V, Ferlazzo VT, Cigala RM, Crea F, De Stefano C, Gembillo G, Romeo A, Longhitano E, Santoro D, Buemi M, Benvenga S (2022) Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients. Int Urol Nephrol 54:2355–2364PubMedCrossRef Cernaro V, Calabrese V, Loddo S, Corsaro R, Macaione V, Ferlazzo VT, Cigala RM, Crea F, De Stefano C, Gembillo G, Romeo A, Longhitano E, Santoro D, Buemi M, Benvenga S (2022) Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients. Int Urol Nephrol 54:2355–2364PubMedCrossRef
37.
Zurück zum Zitat Vaziri ND, Navab M, Fogelman AM (2010) HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 6:287–296PubMedCrossRef Vaziri ND, Navab M, Fogelman AM (2010) HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 6:287–296PubMedCrossRef
38.
Zurück zum Zitat Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, Wang S (2017) Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine 55:66–76PubMedCrossRef Shen Y, Cai R, Sun J, Dong X, Huang R, Tian S, Wang S (2017) Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis. Endocrine 55:66–76PubMedCrossRef
39.
Zurück zum Zitat Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74:1823–1838PubMedCrossRef Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH (2019) Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 74:1823–1838PubMedCrossRef
40.
Zurück zum Zitat Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl 1):S79–S91PubMedCrossRef Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl 1):S79–S91PubMedCrossRef
41.
Zurück zum Zitat Malik J, Tuka V, Mokrejsova M, Holaj R, Tesar V (2009) Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 58:613–621PubMedCrossRef Malik J, Tuka V, Mokrejsova M, Holaj R, Tesar V (2009) Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res 58:613–621PubMedCrossRef
42.
Zurück zum Zitat Lijnen P, Petrov V (1999) Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 31:949–970PubMedCrossRef Lijnen P, Petrov V (1999) Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 31:949–970PubMedCrossRef
43.
Zurück zum Zitat Gross ML, Ritz E (2008) Hypertrophy and fibrosis in the cardiomyopathy of uremia–beyond coronary heart disease. Semin Dial 21:308–318PubMedCrossRef Gross ML, Ritz E (2008) Hypertrophy and fibrosis in the cardiomyopathy of uremia–beyond coronary heart disease. Semin Dial 21:308–318PubMedCrossRef
44.
Zurück zum Zitat Ritz E (2009) Left ventricular hypertrophy in renal disease: beyond preload and afterload. Kidney Int 75:771–773PubMedCrossRef Ritz E (2009) Left ventricular hypertrophy in renal disease: beyond preload and afterload. Kidney Int 75:771–773PubMedCrossRef
45.
Zurück zum Zitat Mominadam S, Ozkahya M, Kayikcioglu M, Toz H, Asci G, Duman S, Ergin P, Kirbiyik S, Ok E, Basci A (2008) Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int 12:322–327PubMedCrossRef Mominadam S, Ozkahya M, Kayikcioglu M, Toz H, Asci G, Duman S, Ergin P, Kirbiyik S, Ok E, Basci A (2008) Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int 12:322–327PubMedCrossRef
Metadaten
Titel
Combinative predictive effect of left ventricular mass index, ratio of HDL and CRP for progression of chronic kidney disease in non-dialysis patient
verfasst von
Leile Tang
Shaomin Li
Xinghua Guo
Jiahui Lai
Peijia Liu
Jia Fang
Xun Liu
Publikationsdatum
18.05.2023
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2024
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03624-y

Weitere Artikel der Ausgabe 1/2024

International Urology and Nephrology 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.